Einstein/Montefiore Department of Medicine


Gabriele DeVos

Gabriele DeVos, MD
Pathogenesis of allergic diseases and the induction of immune tolerance by allergen vaccination (immunotherapy)

Golda Hudes

Golda Hudes, MD, PhD
Asthma and chronic rhinosinusitis

Sunit Jariwala

Sunit Jariwala, MD Immunopathogenic mechanisms of allergic skin diseases; environmental triggers of asthma

Elina Jerschow

Elina Jerschow, MD
Pathogenesis of drug allergies and hypersensitivities, with a particular emphasis on improving diagnostic and therapeutic approaches in drug-related allergic conditions


 David L. Rosenstreich, MD
Effects of inorganic dietary factors on immune reactivity in humans.

Rosenstreich Lab website>> 



Anna BortnickAnna Bortnick
Index of microvascular resistance in microvascular dysfunction, biomarkers and genetics of calcific aortic stenosis, quality issues in TAVR, and intravenous infusion of biologics for the treatment of atherosclerosis.
Yun ChenYun Chen
Mitochondria, Autophagy,Chaperone mediated autophagy (CMA), Cell death, Heart failure.
Angela Cheng-LaiAngela Cheng-Lai
Cardiovascular pharmacotherapy
Luigi Di BiaseLuigi Di Biase
Cardiology and electrophysiology; heart failure.
John FisherJohn Fisher

Joao Daniel FontesJoao Daniel Fontes
CV epidemiology, biomarkers, and cost-effective interventions in public health.
Nikolaos FrangogiannisNikolaos Frangogiannis
Pathophysiology of myocardial infarction, cardiac remodeling, myocardial inflammation, cardiac fibrosis, mechanisms of fibroblast activation, TGF-beta signaling, diabetic cardiomyopathy,
Mario GarciaMario Garcia
Why patients with diastolic heart failure have trouble doing physical exercise and the role of screening imaging tests for predicting cardiovascular events.
Richard KitsisRichard Kitsis
Fundamental mechanisms of cell death; molecular connections among death and autophagy programs; chemical biology; development of first small molecule drugs to reduce heart damage during myocardial infarction.
Jorge KizerJorge Kizer
Obesity and the aging process, and how bioactive factors secreted by adipocytes, skeletal myocytes, and cardiomyocytes, among other cell types, lead to dysregulation of homeostatic mechanisms and promote development of metabolic and cardiovascular diseases.
Thomas McDonaldThomas McDonald
Ion channel behavior in health and disease with a focus on human genetics, structure/function relationships, epigenetics and regulation of protein translation.
Charles NordinCharles Nordin
Cardiovascular pharmacotherapy;diabetes screening, nonpharmacologic causes of QT prolongation, cocaine and beta blockers, proarrhythmic effects of hypoglycemia.
Robert OstfeldRobert Ostfeld
Preventive Cardiology, General Cardiology, Valvular Heart Disease, Echocardiography, Medical Education.
Eugen PalmaEugen Palma
Cardiac Arrhythmias
Ileana PiñaIleana Piña
Rehabilitation of heart disease in patients with heart failure.
Nicholas SibingaNicholas Sibinga
Basic mechanisms of vascular remodeling and obstruction.
Cynthia TaubCynthia Taub
Multimodality cardiac imaging, heart diseases during pregnancy, valvular heart disease, and racial and gender disparity in access to cardiac care
Renjian ZhengRenjian Zheng, PhD
Functional and structural characterization of cardiac ion channel proteins encoded by hERG, KCNQ1(α) and KCNE (β) genes.



Critical Care Medicine

Jen-Ting (Tina) Chen, MD
Asthma and chronic rhinosinusitis

Peter V. Dicpinigaitis, MD
Cough reflex sensitivity 

Lewis Eisen, MD
Point of care ultrasound, simulation training for airway emergencies, situation awareness, teamwork, and leadership.

Hayley Gershengorn, MD
Identifying variations in care delivery for patients with critical illnesses.

Michelle Ng Gong, MD
Prediction and prevention of acute critical illness and their complications.

Aluko A. Hope, MD
Integrating palliative care principles into the care of critically ill older adults; developing approaches to better identify critically ill older adults who are vulnerable to poor outcomes after critical illness.

S. Jean Hsieh, MD
Geriatric critical care; improving cognitive and physical outcomes in survivors of critical illness.

Adam B. Keene, MD

Sharon S. Leung, MD
Performance improvement; palliative care; prevention of sepsis progression.

Rishi Malhotra, MD

Ariel L. Shiloh, MD
Goal directed ultrasonography, focusing on difficult vascular access and shock states.

Graciela J. Soto, MD
ALI/ARDS, sepsis and toll-like receptors.

>Nida Qadir, MD
Asthma and chronic rhinosinusitis



Steven R. Cohen, MD, MPH
Environmental and occupational dermatology and psoriasis



 Gil Atzmon, MD
Role of epigenetics in diseases, aging and longevity.


 Nir Barzilai, M.D.
Biology and genetics of aging.


 Michael A. Brownlee, MD 


 Streamson Chua, MD, PhD
Genetic contribution to the chronic disease of obesity, diabetes, and diabetes complications.


 Jill P. Crandall, MD


 Ruth Freeman, MD
Menopause, hormone replacement therapy, osteoporosis and vitamin D deficiency, and other endocrine disorders


 Jeffrey Gonzalez, PhD
Factors associated with treatment nonadherence in and developing interventions to improve treatment adherence among patients with chronic illness, particularly diabetes and HIV/AIDS.


 Meredith A. Hawkins, MD
Effects of nutrient deficiency and excess on insulin resistance, nutritional regulation of adipose tissue inflammation, and regulation of hepatic glucose production in diabetes mellitus.


 Young-Hwan Jo, PhD
Cellular pathogenesis of obesity.


 Irwin J. Kurland, MD, PhD

 Sofiya Milman, MD
Genetics associated with high HDL levels and longevity.


 Jeffrey Pessin, PhD
Insulin signaling at the molecular level, regulation of glucose uptake and metabolism at the cellular molecular level, and the integrative systems of metabolism in normal and pathophysiologic states in genetic rodent models.


 Gary J. Schwartz, PhD
How the gut and the brain interact to regulate food intake and associated metabolic processes.


 Rajat Singh, MD, MBBS
Autophagy and integrative physiology.


 Daniel T. Stein, MD 


 Martin I. Surks, M.D. 


 Yaron Tomer, MD
Immunogenetic and epigenetic mechanisms causing autoimmune thyroiditis and type 1 diabetes, and how to translate them into novel immune therapies for these diseases.


 Elizabeth A. Walker, PhD


 Fajun Yang, PhD
Transcriptional control of lipid metabolism.


 Joel Zonszein, MD 


Gastroenterology & Liver Diseases

Olga Aroniadis, MD, MSc
Intestinal microbiome and its implication in health and disease, Clostridium difficile infection and colon ischemia.


Lawrence Brandt, MD
ischemic and vascular disorders of the gastrointestinal system, inflammatory bowel diseases, colitis, geriatric gastroenterology, AIDS, and endoscopic technique.


Carolina Elisovitch


Sanjeev Gupta, MD, MBBS
Liver cell-based therapies and relevant aspects of stem cell biology.


Harmit Kalia, DO
NAFLD, Hepatitis B, complications of end stage liver disease and liver transplantation.


Dana Lukin, MD, PhD
Inflammatory Bowel Disease Clinical Trials Crohn's Disease Ulcerative Colitis Intestinal Permeability.


Parvathi Myer, MD
Disparities in colorectal cancer in both sporadic and hereditary colorectal cancer.


John Reinus, MD
Liver diseases and related topics

 Charles E. Rogler, PhD
Fundamental mechanisms of microRNA regulation of gene expression and cell fate.


 Leslie E. Rogler, PhD 


 Jayanta Roy-Chowdhury, MBBS
Liver-directed gene therapy.


 Namita Roy-Chowdhury, PhD
Liver-based inherited metabolic diseases, mainly, inherited disorders of Bilirubin Glucuronidation and Primary Hyperoxaluria type 1.


Jonathan Schwartz, MD
Acute and chronic liver diseases.


 David A. Shafritz, MD
Liver repopulation and gene therapy using fetal liver stem/progenitor cells and genetically re-engineered adult hepatocytes.


Samuel Sigal, MD
Treatment of viral hepatitis, ascites, hepatic encephalopathy, and hepatorenal syndrome.


 Allan W. Wolkoff, MD
Basic understanding of hepatocyte function and relation to disease.


General Internal Medicine

 Julia Arnsten, MD, MPH
Buprenorphine and neurocognitive function in opioid-dependent drug users, training physicians in clinical addiction research.


 Marcus Bachhuber, MD 
Addiction treatment in the Affordable Care Act, medical and recreational marijuana laws, prescription drug abuse


 Oni Blackstock, MD
Do group medical visits improve HIV medication adherence among women with HIV/AIDS?


 James Brust, MD
Examining a new drug for patients with drug-resistant tuberculosis in South Africa


 Chinazo Cunningham, MD, MS 
Primary care access to buprenorphine treatment for opioid addiction; Do financial incentives for abstinence from illicit drugs lead to improved HIV outcomes?


 Aaron Fox, MD 
Peer mentorship to assist individuals with opioid use disorders enter addiction treatment after jail/prison release, medical homes for individuals returning from jail or prison


 Alain Litwin, MD 
Caring for injection drug users with hepatitis C


 Shadi Nahvi, MD, MS 
Smoking cessation for opioid treatment patients


 Brianna Norton, DO 
Group HCV evaluation and primary-care based HCV treatment for persons who inject drugs


 Gerald Paccione, MD
Global health: Montefiore-Einstein campus in East Africa (Kisoro District Hospital, Uganda)


 Viraj Patel, MD
HIV treatment adherence in India, HIV prevention through social media, gender and sexual minority health research


 Hector Perez, MD
Healthcare barriers in persons with communication disabilities


 Anjali Sharma, MD 
Pain in HIV-infected and uninfected women (NIH)


 Joanna Starrels, MD, MS 
Management of chronic pain in people living with HIV; opioid misuse and addiction in people taking opioid analgesics



Helena Blumen, PhD
Human memory, cognitive aging, and cognitive neuroscience


Mirnova E. Ceide, M.D.


Thiruvinvamalai S. Dharmarajan, MD, MBBS
Geriatrics, nutrition, anemia and anticoagulation


Claudene George, MD
Geriatrics, nutrition, anemia and anticoagulation


 Joe Verghese, MBBS
Influence of cognitively stimulating activities on reducing risk of dementia, the role of divided attention tasks in predicting outcomes such as disability and cognitive decline, cognitive interventions, and global health



 Seetharama A. Acharya, PhD 


 Henny Billett, MD
Risk factors for thrombosis and microvascular disease, with emphasis on epidemiological aspects and outcomes research


 Eric E. Bouhassira, PhD
Developing hematopoietic (blood forming) stem cells that can differentiate into red blood cells, T cells, platelets, and all other cell types that comprise blood


 Paul S. Frenette, MD
How hematopoietic stem cells and mature blood cells traffic in vivo


 John M. Greally, MB, BCh, PhD
Understanding models of genetic susceptibility to human disease, especially those affecting children


 Rhoda E. Hirsch, PhD
Hemoglobinopathy HbE (ß26 Glu Lys) and related diseases.


 Michael B. Stemerman, MD
How LDL may alter the function of the vascular endothelium


Hospital Medicine

Sarah Baron, MD
Systems-based improvement methodologies and error reporting


Cristina M. Gonzalez, MD
Health disparities and advocacy education


 William N. Southern, MD, MS
Hospital medicine outcomes


Infectious Diseases

Jacqueline M. Achkar, MD, MS
Antibody responses to immunodominant proteins of Mycobacterium tuberculosis, TB diagnostics, TB in immigrants, immune responses in vulvovaginal candidiasis


Stephen G. Baum, MD
Viral and mycoplasmal pneumonia


Michela Catalano, MD
Infections in health care workers, vaccines


 John Chan, MD

Mycobacterium tuberculosis-host interaction


Christina M. Coyle, MD, MS
Clinical tropical medicine


Johanna P Daily, MD, MS
Plasmodium falciparum pathogenesis; drug resistance; host response


Robert Grossberg, MD
Treatment adherence, HIV quality of care, HIV clinical trials


Carol Harris, MD
International AIDS


Elizabeth R. Jenny-Avital, MD
Clinical aspects of TB, HIV related immune reconstitution syndrome, CNS HIV disease


Marla Keller, MD
Clinical trials to assess microbicide safety, genital tract mucosal immunity, HIV infection in women


Kami Kim, MD
Molecular pathogenesis of Toxoplasma gondii and Plasmodium species, epigenetics, chemotherapy of parasitic infections, vaccine design


Grace Minamoto, MD
Infections in immunocompromised hosts (HIV, transplantation, cancer)


Victoria A. Muggia, MD
Transplant infectious disease, HIV primary care


Joshua Nosanchuk, MD, FIDSA, FACP
Microbial pathogenesis, virulence factors, antibody immunity


Belinda Ostrowsky, MD, MPH
Antimicrobial stewardship, antimicrobial resistance, public health


Liise-anne Pirofski, MD
Immunity to encapsulated pathogens, antibody immunity, vaccine development


Paul Riska, MD
Diagnosis, treatment and epidemiology of Clostridium difficile; tuberculosis


Jonathan Shuter, MD
Tobacco use in persons living with HIV/AIDS, adherence to antiretroviral medications


David K. Stein, MD
HIV therapeutics


Herbert B. Tanowitz, MD
Professor, Department of Pathology
Pathogenesis of parasitic diseases, Chagas disease, and cerebral malaria


Louis M. Weiss, MD, MPH
Pathogenesis of parasitic diseases, Chagas disease, and cerebral malaria


Barry S. Zingman, MD
HIV and infectious diseases administration and care; HIV quality and guidelines development; new antiretroviral agents; HIV/Hepatitis C co-infection; HIV testing



Matthew Abramowitz, MD
Chronic metabolic acidosis, skeletal muscle function, and functional impairment in patients with chronic kidney disease.


Enver Akalin, MD
Mechanisms of acute and chronic rejection using microarray technology and immune monitoring of kidney transplant recipients


 Yuling Chi, PhD
Molecular and cellular mechanisms of metabolic disorders, diabetic complications, and developing pharmacological and nutraceutical therapeutics.


Maria Coco, MD 


Ladan Golestaneh, MD
Role of renal resistive index and NGAL as predictors of AKI incidence in the ICU


Michal L. Melamed, MD
Epidemiology of and ethnic and racial disparities in chronic kidney disease and its complications, the epidemiology and health consequences of vitamin D deficiency, and acute kidney injury


Michele H. Mokrzycki, MD
Hemodialysis vascular access related complications


 Victor L. Schuster, MD 


Pulmonary Medicine


David W. Appel, MD
Sleep medicine; sleep and cough; sleep and gastroesophageal reflux among people with obstructive sleep apnea; obstructive sleep apnea and aspiration, anemia of aging, CHF among African Americans; restless leg syndrome


Peter V. Dicpinigaitis, MD
Methods of cough reflex sensitivity measurement with the tussive agent capsaicin


David J. Prezant, MD
Pulmonary physiology, firefighter health and safety, and the health impact of World Trade Center collapse on NYC firefighters and EMS rescue workers


 Simon D. Spivack, MD, MPH 



 Irene Blanco, MD
Improving the clinician’s ability to predict and ultimately improve the outcome of lupus nephritis


 Anna Broder, MD
Clinical and translational research in systemic lupus, antiphospholipid syndrome and other rheumatologic diseases


 John A. Hardin, MD
Systemic lupus erythematosus and autoantibodies


 Steven A. Porcelli, MD
Control of acquired immune responses by T cells


 Chaim Putterman, MD
Systemic lupus erythematosus (SLE)

Media Spotlight

Drug that Boosts Brain's Cleansing System Improved Symptoms in Alzheimer's Mouse Model

Ana Maria Cuervo, M.D., Ph.D. and Evripidis Gavathiotis, Ph.D., developed an experimental drug that reinvigorates a cellular cleaning mechanism and reversed key symptoms of Alzheimer's disease in mice. Dr. Cuervo is professor of developmental and molecular biology, co-director of the Institute for Aging Research, and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein. Dr. Gavathiotis is professor of biochemistry and of medicine.

(Thursday, Sep 02, 2021)

coverage on other stories

Biostatistics Resources

Biostatistics Resources for Department of Medicine Faculty Albert Einstein College of Medicine Montefiore Medical Center Bronx NY

Department of Medicine faculty are eligible for biostatistical support, with priority given to junior faculty. more 


Shared Facilities & Cores

Biostatistics Resources for Department of Medicine Faculty Albert Einstein College of Medicine Montefiore Medical Center Bronx NY

Shared facilities and cores provide access to techniques and services requiring expensive instrumentation, specialized facilities, and/or a high degree of expertise. listing 

Click here to log in